Paul Tolstoshev
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul Tolstoshev.
Lung | 1978
Ronald G. Crystal; Jack D. Fulmer; Bruce J. Baum; John Bernardo; Kathryn H. Bradley; Sally D. Bruel; Norton A. Elson; Gerald A. Fells; Victor J. Ferrans; James E. Gadek; Gary W. Hunninghake; Oichi Kawanami; Jeffrey A. Kelman; Bruce R. Line; John A. McDonald; Bryon D. McLees; William C. Roberts; David M. Rosenberg; Paul Tolstoshev; Edwyna Von Gal; Steven E. Weinberger
Idiopathic pulmonary fibrosis (IPF) is a usually fatal disorder of lung with clearly defined clinical, roentgenographic, physiologic, morphologic, scintigraphic and bronchoalveolar lavage features. Current concepts of the pathogenesis of this disorder suggest a central role for a chronic alveolitis in causing changes in parenchymal cell populations and derangements in interstitial collagen. Of the many inflammatory and immune effector cells comprising the alveolitis of IPF, it is likely that the neutrophil is the most important mediator of parenchymal damage. To follow the status of lung neutrophils in patients with this disease, two methods have been utilized. Both gallium-67 scanning and bronchoalveolar lavage quantitate the extent of the alveolitis and can be used to stage and follow these patients. The treatment of IPF remains controversial, but it is likely that corticosteroids reduce the alveolitis and prolong the lifespan of these patients.
Biochemical and Biophysical Research Communications | 1979
Paul Tolstoshev; Roberta Haber; Ronald G. Crystal
Abstract The fractionation of fetal calf tendon messenger RNA in 85 percent formamide sucrose gradients shows a separation of the mRNAs coding for pro α1(I) and pro α2 chains of type I collagen. This difference in sedimentation in denaturing gradients suggests that pro α2 mRNA is approxmately 1000 bases shorter than pro α1(I) mRNA. However, such a size difference is significantly greater than would be predicted from consideration of the size of the polypeptide chains coded for by these mRNAs, and thus, residual secondary structure in the mRNAs may contribute to these apparent size differences.
web science | 1976
Raymond Dalgleish; Robert Williamson; Paul Tolstoshev
Complementary DNA (cDNA) was prepared with viral RNA-directed DNA polymerase from purified baboon globin messenger RNA (mRNA). Homologous and heterologous hybrids between human and baboon mRNAs and cDNAs were compared for extent of hybridisation and thermal stability. Higher mRNA inputs to the hybridizations were required to reach saturation in the heterologous cases. The melting temperature of the heterologous hybrid was 5 degrees C lower than the homologous hybrid. Between these two primates, divergence has occurred in the globin gene to a smaller extent than that possible from third position changes in the coding sequences of the divergence of total DNA. Globin cDNA prepared from baboon will not in general be useful as a probe for human globin mRNA or human globin gene sequences.
Nucleic Acids Research | 1983
Michael Jaye; Fabienne Schamber; Alain Balland; Vipin Kohli; Annie Findeli; Paul Tolstoshev; Jean-Pierre Lecocq
web science | 1986
M. Miskulin; Raymond Dalgleish; Barbara Kluve-Beckerman; Stephen I. Rennard; Paul Tolstoshev; Mark L. Brantly; Ronald G. Crystal
Human Gene Therapy | 1994
Nanette Mittereder; Soonpin Yei; Cindy J. Bachurski; John Cuppoletti; Jeffrey A. Whitsett; Paul Tolstoshev; Bruce C. Trapnell
Nature | 1985
Werner Altenburger; René Elkaim; Karin Dott; Annick Dieterlé; Robert Drillien; Jean-Pierre Cazenave; Paul Tolstoshev; Jean-Pierre Lecocq
Journal of Biological Chemistry | 1981
Paul Tolstoshev; Richard A. Berg; S I Rennard; K H Bradley; Bruce C. Trapnell; Ronald G. Crystal
Archive | 1985
Paul Tolstoshev; Richard Harvey; Michael Courtney; Jean-Pierre Lecocq
Journal of Biological Chemistry | 1981
Paul Tolstoshev; R Haber; Bruce C. Trapnell; Ronald G. Crystal